These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 16146077)
1. Neurological manifestation of CMV disease after allogeneic haematopoietic stem cells transplantation--a case report. Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):198-200. PubMed ID: 16146077 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients. Correia-Silva Jde F; Victória JM; Guimarães AL; Salomão UE; de Abreu MH; Bittencourt H; Gomez RS Oral Dis; 2007 Mar; 13(2):163-9. PubMed ID: 17305617 [TBL] [Abstract][Full Text] [Related]
3. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation. Du J; Liu J; Gu J; Zhu P Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570 [TBL] [Abstract][Full Text] [Related]
5. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation. He JD; Liu YL; Wang ZF; Liu DH; Chen H; Chen YH Chin Med J (Engl); 2008 Jul; 121(14):1285-9. PubMed ID: 18713549 [TBL] [Abstract][Full Text] [Related]
6. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease. Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814 [TBL] [Abstract][Full Text] [Related]
7. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringdén O Haematologica; 2006 Jan; 91(1):78-83. PubMed ID: 16434374 [TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Hernández-Boluda JC; Lis MJ; Goterris R; Arbona C; Terol MJ; Tormo M; Solano C Transpl Infect Dis; 2005 Jun; 7(2):93-6. PubMed ID: 16150099 [TBL] [Abstract][Full Text] [Related]
10. The impact of early rehabilitation on the duration of hospitalization in patients after allogeneic hematopoietic stem cell transplantation. Inoue J; Ono R; Okamura A; Matsui T; Takekoshi H; Miwa M; Kurosaka M; Saura R; Shimada T Transplant Proc; 2010 Sep; 42(7):2740-4. PubMed ID: 20832579 [TBL] [Abstract][Full Text] [Related]
11. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients. Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638 [TBL] [Abstract][Full Text] [Related]
15. Small intestinal CMV disease detected by capsule endoscopy after allogeneic hematopoietic SCT. Kakugawa Y; Kim SW; Takizawa K; Kikuchi T; Fujieda A; Waki F; Fukuda T; Saito Y; Shimoda T; Takaue Y; Saito D Bone Marrow Transplant; 2008 Aug; 42(4):283-4. PubMed ID: 18500371 [No Abstract] [Full Text] [Related]
16. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection in paediatric haemopoietic stem cell transplantation. Chong AL; Clinton F; Breatnach F; O'Marcaigh A; Butler K; O'Meara A Ir Med J; 2008 Jan; 101(1):17-21. PubMed ID: 18369019 [TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide. Ehlert K; Groll AH; Kuehn J; Vormoor J Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile. Paris C; Kopp K; King A; Santolaya ME; Zepeda AJ; Palma J Pediatr Blood Cancer; 2009 Sep; 53(3):453-8. PubMed ID: 19418548 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment. Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]